OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.

The company’s first product- the InSpace™ System is indicated for Rotator Cuff syndrome as it alleviates pain in patients. The InSpace™ System has the CE mark and is commercially available in Europe. 

In the USA, the InSpace is an investigational device. Limited by Federal (or United States) law to investigational use. Exclusively for clinical investigations.

Company Growth (employees)
Caesarea, IL
Size (employees)
28 (est)-6%
OrthoSpace was founded in 2009 and is headquartered in Caesarea, IL

OrthoSpace Office Locations

OrthoSpace has offices in Caesarea, Milano, Fribourg, Kiel and in 10 other locations
Caesarea, IL
Macquarie Park, AU
Seoul, KR
Bengaluru, IN
Moskva, RU
Agia Paraskevi, GR
Warszawa, PL
Vlaardingen, NL
Pozuelo de Alarcón, ES
Kingston upon Hull, GB
Viriat, FR
Kiel, DE
Fribourg, CH
Milano, IT

OrthoSpace Metrics

OrthoSpace Summary

Founding Date


Total Funding

$15 m

Latest funding size

$7 m

Time since last funding

4 months


We estimate that OrthoSpace's latest funding round in December 2016 was $7 m. In total, OrthoSpace has raised $15 m

OrthoSpace Company Life

You may also be interested in